Priority 3 from the Sight Loss and Vision PSP Cataract

UNCERTAINTY: How can cataract progression be slowed down? (JLA PSP Priority 3)
Overall ranking 3
JLA question ID 0014b/3
Explanatory note No relevant systematic reviews identified at the time of the PSP
Evidence None identified
Health Research Classification System category Eye
Extra information provided by this PSP
Original uncertainty examples This is an indicative uncertainty and was submitted 3 times, and the following submissions were merged to form this uncertainty: How can we slow down cataract progression?
Systematic reviews in preparation (at the time of PSP) Dubois VDJP, Bastawrous A. N-acetylcarnosine (NAC) drops for age-related cataract (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 12. Art. No.: CD009493. DOI: 10.1002/14651858.CD009493.
Ongoing controlled trials None identified
Submitted by Patients
Outcomes to be measured Management and or change of symptoms; adverse effects or complications; acceptability to patients or carers; time to return to work or normal activity; time in hospital and or needing health or social care services; health related quality of life; and costs
PSP information
PSP unique ID 0014b
PSP name Sight Loss and Vision - Cataract
Total number of uncertainties identified by this PSP. 42  (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
Date of priority setting workshop April and May 2013